Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 13/20 | 0.47 |
| ▸ | CDK2 | P24941 | 5/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | CDK9 | P50750 | 1/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | CDK7 | P50613 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24667992 | 0.97 | GSK3B (0.48) | GSK3BCDK2CCNE1CHEK1CDK1 | |
| SCHEMBL24669687 | 0.87 | GSK3B (0.45) | GSK3BCDK2CCNE1CHEK1CDK1 | |
| SCHEMBL24670338 | 0.83 | CDK2 (0.53) | GSK3BCDK2CCNE1CDK1CDK9 | |
| SCHEMBL24670103 | 0.79 | GSK3B (0.56) | GSK3BCDK2CCNE1CDK1CDK9 | |
| SCHEMBL24670112 | 0.74 | GSK3B (0.57) | GSK3BCDK2CCNE1 | |
| SCHEMBL13290022 | 0.72 | GSK3B (0.54) | GSK3BCDK2CCNE1CDK1CDK9 | |
| SCHEMBL13122702 | 0.72 | GSK3B (0.69) | GSK3BCDK2CCNE1 | |
| SCHEMBL13304924 | 0.68 | GSK3B (0.76) | GSK3BCDK2CCNE1CHEK1CDK1 | |
| SCHEMBL13290026 | 0.67 | GSK3B (0.53) | GSK3BCDK2CCNE1CDK1CDK9 | |
| SCHEMBL13122700 | 0.67 | GSK3B (0.68) | GSK3BCDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022187693-A1 | COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES | UMBRA THERAPEUTICS INC. (US) | 2022-09-09 | — | — | WO | disclosed |